Brought to you by:
More than half of medical students altered Match ranking order after post-virtual interview site visits, APDVS survey finds
Amid the build-up to residency Match Day 2024, the Association of Program Directors in Vascular Surgery (APDVS) has delivered data from a VISIT (Vascular In-Person for Students in the Match Trial) pilot study that took place last year showing some…
Breakthrough Device designation granted for Efemoral scaffold system designed to treat CLTI
Efemoral Medical has announced the granting of Food and Drug Administration (FDA) Breakthrough Device status for its novel Efemoral vascular scaffold system (EVSS) designed to treat de novo or restenotic lesions of the infrapopliteal arteries in patients with chronic limb-threatening ischemia (CLTI).…
SAVS 2024: A journey to the heart of DEI like no other
David L. Cull, MD, delivers a captivating presidential address, laying bare his own challenging journey as a vascular surgeon and the hidden lessons on diversity, equity and inclusion his life story may hold. Like nearly everyone else assembled, when Alan…
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a reflection on lessons learnt one year on from BEST-CLI; Southern Vascular’s election of its first female…
Re-evaluating aortoiliac endarterectomy: Case series shows ‘acceptable durability’
The uncommonly performed aortoiliac endarterectomy—one of the open procedures on which the vascular surgical specialty was founded—provides acceptable durability in aortoiliac occlusive disease patients with smaller native vessels, especially among females, a 25-patient case series review performed at Louisiana State…
‘Get a Pulse on PAD’: Multi-society public awareness campaign launched
The Society for Vascular Surgery (SVS), in partnership with three other medical societies operating in the vascular disease space that form the PAD Pulse Alliance, is taking part in a peripheral arterial disease (PAD) public awareness campaign called “Get a…
Measuring plaque inflammation via SCAIL scores may improve carotid stenosis risk stratification
The use of a relatively novel scoring system, referred to as Symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL), has produced favourable predictive qualities versus the Oxford carotid stenosis tool (OCST) and Essen stroke risk score (ESRS). According to researchers, the SCAIL…
UK MHRA update: Paclitaxel-coated device increased mortality risk is withdrawn for PAD
Following a review, the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has updated guidance on the use of paclitaxel-coated devices stating that such devices can be considered for the treatment of peripheral arterial disease (PAD), including intermittent claudication and critical…
Serration angioplasty associated with reduced recoil in infrapopliteal arteries compared with plain balloon angioplasty
A study comparing the extent of early infrapopliteal recoil after serration and plain balloon angioplasty has found the former produces “substantially less” arterial recoil in the treatment of these lesions and has demonstrated “technical feasibility” in measuring early recoil using…
SVS points to 2023 achievements, challenges in coming year
The Society for Vascular Surgery (SVS) reflects on a year marked by notable achievements on multiple fronts. In a communication to members in mid-December, Executive Director, Kenneth M. Slaw, PhD, underscored the organization’s growth, collaborative endeavors and key milestones attained…